Ibrahim Ragab Eissa
Impact in
- Genetics top 10%
- Virus-based gene therapy research
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Co-authors
- Hideki Kasuya (10 shared papers)Yoshinori Naoe (10 shared papers)Yasuhiro Kodera (8 shared papers)Maki Tanaka (8 shared papers)Toru Ichinose (7 shared papers)Nobuaki Mukoyama (7 shared papers)Noriyuki Miyajima (6 shared papers)Shigeru Matsumura (9 shared papers)
- Journals
- Cancers (1 paper)Scientific Reports (1 paper)Molecular Therapy — Oncolytics (1 paper)Molecular Oncology (1 paper)Frontiers in Oncology (1 paper)
- Partner nations
- JapanEgyptUnited States
In The Last Decade
Ibrahim Ragab Eissa
12 papers receiving 296 citations
Peers
Comparison fields: 5 of 40
- Genetics 198
- Oncology 190
- Biotechnology 57
- Immunology 69
- Animal Science and Zoology 22
Countries citing papers authored by Ibrahim Ragab Eissa
This map shows the geographic impact of Ibrahim Ragab Eissa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ibrahim Ragab Eissa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ibrahim Ragab Eissa more than expected).
Fields of papers citing papers by Ibrahim Ragab Eissa
This network shows the impact of papers produced by Ibrahim Ragab Eissa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ibrahim Ragab Eissa. The network helps show where Ibrahim Ragab Eissa may publish in the future.
Co-authors
The 25 scholars most cited alongside Ibrahim Ragab Eissa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 121 | |
| 2 | 2017 | 78 | |
| 3 | 2023 | 27 | |
| 4 | 2019 | 25 | |
| 5 | 2021 | 17 | |
| 6 | 2022 | 11 | |
| 7 | 2021 | 8 | |
| 8 | 2024 | 7 | |
| 9 | 2024 | 6 | |
| 10 | 2025 | 3 | |
| 11 | 2011 | 2 | |
| 12 | 2021 | 2 |
About Ibrahim Ragab Eissa
Ibrahim Ragab Eissa is a scholar working on Genetics, Oncology, Immunology, Biotechnology and Molecular Biology, having authored 12 papers that have together received 307 indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), CAR-T cell therapy research (5 papers), Cancer Research and Treatments (4 papers), interferon and immune responses (3 papers), Immune cells in cancer (1 paper), Metabolism, Diabetes, and Cancer (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Genetics (198 citations), Oncology (190 citations), Biotechnology (57 citations), Immunology (69 citations) and Animal Science and Zoology (22 citations). Ibrahim Ragab Eissa has collaborated with scholars based in Japan, Egypt and United States. Frequent co-authors include Hideki Kasuya, Yoshinori Naoe, Yasuhiro Kodera, Maki Tanaka, Toru Ichinose, Nobuaki Mukoyama, Noriyuki Miyajima, Shigeru Matsumura, Zhiwen Wu and Branko Aleksić. Their work appears in journals such as Cancers, Scientific Reports, Molecular Therapy — Oncolytics, Molecular Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.